Overview
Meifang Xu practices in Fuzhou, China. Xu is highly rated in 1 condition, according to our data. Their top areas of expertise are Angioimmunoblastic T-cell Lymphoma, Colorectal Cancer, T-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Their clinical research consists of co-authoring 33 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Angioimmunoblastic T-cell Lymphoma
- Experienced
- Colorectal CancerXu isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal Cancer
- Lymphofollicular Hyperplasia
- Neuroendocrine TumorXu isExperienced. Learn about Neuroendocrine Tumor.
- Non-Hodgkin LymphomaXu isExperienced. Learn about Non-Hodgkin Lymphoma.
- T-Cell LymphomaXu isExperienced. Learn about T-Cell Lymphoma.